Virpax Pharmaceuticals, Inc. (Nasdaq:VRPX)

Health Care/Life Sciences • Pharmaceuticals

CIK 1708331

Company

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Address
1055 Westlakes Drive
Suite 300
Berwyn, Pennsylvania 19312

Employees
7

Stock Info

Close
$4.3000

Day Range
3.7100 - 4.3400

52 Week Range
2.4020 - 11.7740

Average volume
30.68K

Short Interest
6.24K (02/15/24)

% of Float Shorted
0.72%

Market Cap
$4.41M

Revenue
N/A

Net Income
-$21.65M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$11.6225

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chief Executive Officer & Director
Gerald W Bruce

Director, Chief Medical Officer & Executive VP
Jeffrey A Gudin MD

Director
Barbara A Ruskin PhD

Chairman
Eric Floyd PhD, EMBA

Independent Director
Vanila M Singh MD

Independent Director
Jerrold Sendrow

Independent Director
Thani Jambulingam PhD

Independent Director
Michael F Dubin CPA

SEC filings

Date	Form	Event
10 Oct, 2024	10-K/A
10 Oct, 2024	10-K/A
9 Oct, 2024	8-K/A
7 Oct, 2024	8-K
4 Oct, 2024	8-K
3 Oct, 2024	8-K
3 Oct, 2024	8-K
25 Sep, 2024	8-K
17 Sep, 2024	8-K
13 Aug, 2024	S-1/A
13 Aug, 2024	8-K
12 Aug, 2024	10-Q
30 Jul, 2024	8-K
29 Jul, 2024	S-1
26 Jul, 2024	8-K
24 Jul, 2024	8-K
15 Jul, 2024	3
15 Jul, 2024	8-K
12 Jul, 2024	D
10 Jul, 2024	3
10 Jul, 2024	8-K
10 Jul, 2024	4
9 Jul, 2024	3
9 Jul, 2024	3
9 Jul, 2024	4
9 Jul, 2024	4
8 Jul, 2024	8-K
8 Jul, 2024	DEFA14A
3 Jul, 2024	8-K
12 Jun, 2024	ARS
12 Jun, 2024	DEF 14A
23 May, 2024	SC 13G
17 May, 2024	8-K
16 May, 2024	424B4
14 May, 2024	EFFECT
14 May, 2024	CORRESP
13 May, 2024	10-Q
13 May, 2024	8-K
13 May, 2024	S-1/A
9 May, 2024	CORRESP
3 May, 2024	CORRESP
3 May, 2024	CORRESP
2 May, 2024	8-K
2 May, 2024	CORRESP
2 May, 2024	S-1/A
30 Apr, 2024	8-K
26 Apr, 2024	S-1/A
23 Apr, 2024	UPLOAD
18 Apr, 2024	S-1
5 Apr, 2024	S-8
3 Apr, 2024	8-K
26 Mar, 2024	10-K
26 Mar, 2024	8-K
18 Mar, 2024	8-K
1 Mar, 2024	8-K
31 Jan, 2024	4
31 Jan, 2024	4
31 Jan, 2024	4
31 Jan, 2024	4
31 Jan, 2024	4
31 Jan, 2024	4
31 Jan, 2024	4
31 Jan, 2024	4
31 Jan, 2024	4
2 Jan, 2024	SC 13G/A
29 Dec, 2023	8-K
13 Dec, 2023	8-K
7 Dec, 2023	10-Q
7 Dec, 2023	8-K
7 Dec, 2023	DEF 14A
21 Nov, 2023	PRE 14A
17 Nov, 2023	8-K
17 Nov, 2023	8-K	CEO Change
16 Nov, 2023	8-K
15 Nov, 2023	NT 10-Q
11 Oct, 2023	8-K
3 Oct, 2023	3
5 Sep, 2023	8-K
16 Aug, 2023	4/A
16 Aug, 2023	8-K
14 Aug, 2023	10-Q
14 Aug, 2023	8-K
26 Jul, 2023	8-K
22 Jun, 2023	DEFA14A
21 Jun, 2023	3
21 Jun, 2023	8-K
21 Jun, 2023	4
7 Jun, 2023	8-K
7 Jun, 2023	ARS
7 Jun, 2023	DEF 14A
12 May, 2023	8-K
12 May, 2023	10-Q
26 Apr, 2023	4
14 Apr, 2023	8-K
28 Mar, 2023	4
28 Mar, 2023	8-K
28 Mar, 2023	3
22 Mar, 2023	10-K
22 Mar, 2023	8-K
13 Mar, 2023	8-K
17 Feb, 2023	8-K
14 Feb, 2023	SC 13G/A
7 Feb, 2023	4/A
27 Jan, 2023	4
27 Jan, 2023	4
27 Jan, 2023	4
26 Jan, 2023	SC 13G/A
10 Jan, 2023	SC 13G/A
4 Jan, 2023	4
4 Jan, 2023	4
4 Jan, 2023	4
4 Jan, 2023	4
4 Jan, 2023	4
29 Dec, 2022	8-K
22 Nov, 2022	S-8
9 Nov, 2022	10-Q
9 Nov, 2022	8-K
18 Oct, 2022	EFFECT
14 Oct, 2022	CORRESP
13 Oct, 2022	UPLOAD
7 Oct, 2022	S-3
15 Aug, 2022	8-K
15 Aug, 2022	10-Q
25 Jul, 2022	8-K
27 Jun, 2022	8-K
21 Jun, 2022	DEFA14A
15 Jun, 2022	DEFA14A
15 Jun, 2022	DEF 14A
26 May, 2022	4
20 May, 2022	4
20 May, 2022	4
16 May, 2022	10-Q
16 May, 2022	8-K
6 May, 2022	S-8
27 Apr, 2022	4
31 Mar, 2022	8-K
31 Mar, 2022	10-K
15 Mar, 2022	8-K
25 Feb, 2022	4/A
25 Feb, 2022	4/A
25 Feb, 2022	4/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G
4 Feb, 2022	SC 13G
2 Feb, 2022	4
2 Feb, 2022	4
2 Feb, 2022	4
5 Jan, 2022	4
5 Jan, 2022	4
5 Jan, 2022	4
5 Jan, 2022	4
5 Jan, 2022	4
5 Jan, 2022	4
4 Jan, 2022	SC 13G/A
24 Nov, 2021	4
22 Nov, 2021	4
15 Nov, 2021	10-Q
15 Nov, 2021	8-K
23 Sep, 2021	SC 13G
21 Sep, 2021	SC 13G
20 Sep, 2021	SC 13G
15 Sep, 2021	424B4
15 Sep, 2021	POS EX
14 Sep, 2021	EFFECT
10 Sep, 2021	FWP
9 Sep, 2021	CORRESP
9 Sep, 2021	CORRESP
9 Sep, 2021	UPLOAD
9 Sep, 2021	S-1
1 Sep, 2021	DRS
10 Aug, 2021	10-Q
10 Aug, 2021	8-K
5 Aug, 2021	4
5 Aug, 2021	3
5 Aug, 2021	3
30 Jul, 2021	8-K
18 May, 2021	8-K
17 May, 2021	10-Q
23 Apr, 2021	S-8
19 Apr, 2021	8-K
13 Apr, 2021	8-K
9 Apr, 2021	4
9 Apr, 2021	4
9 Apr, 2021	4
9 Apr, 2021	4
9 Apr, 2021	4
9 Apr, 2021	4
9 Apr, 2021	4
9 Apr, 2021	4
9 Apr, 2021	4
31 Mar, 2021	10-K
1 Mar, 2021	4
19 Feb, 2021	4
18 Feb, 2021	POS EX
18 Feb, 2021	424B4	IPO completed
16 Feb, 2021	3
16 Feb, 2021	3
16 Feb, 2021	3
16 Feb, 2021	3
16 Feb, 2021	3
16 Feb, 2021	3
16 Feb, 2021	3
16 Feb, 2021	3
16 Feb, 2021	CERT
16 Feb, 2021	S-1MEF
16 Feb, 2021	EFFECT
16 Feb, 2021	SEC STAFF
16 Feb, 2021	3
16 Feb, 2021	3
11 Feb, 2021	8-A12B
11 Feb, 2021	CORRESP
11 Feb, 2021	CORRESP
2 Feb, 2021	S-1/A
8 Jan, 2021	S-1/A
8 Jan, 2021	FWP
8 Jan, 2021	CORRESP
31 Dec, 2020	UPLOAD
16 Dec, 2020	CORRESP
7 Dec, 2020	SEC STAFF
3 Dec, 2020	UPLOAD
20 Nov, 2020	CORRESP
23 Oct, 2020	UPLOAD
9 Oct, 2020	CORRESP
8 Sep, 2020	UPLOAD

Last update:2024-03-06 13:40:55.950712

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.